Use of drug with the therapy of asthma as monotherapy with out a concomitant ICS is contraindicated; use only as additional therapy for sufferers with bronchial asthma who are at present taking but are inadequately controlled on an ICS; never use drug for individuals whose asthma is sufficiently managed on https://fccp13579.dgbloggers.com/28745444/about-atazanavir-sulfate